118 related articles for article (PubMed ID: 31225492)
1. New insights into the role of soluble E-cadherin in tumor angiogenesis.
Tang MKS; Ip PP; Wong AST
Cell Stress; 2018 Aug; 2(9):236-238. PubMed ID: 31225492
[TBL] [Abstract][Full Text] [Related]
2. Soluble E-cadherin promotes tumor angiogenesis and localizes to exosome surface.
Tang MKS; Yue PYK; Ip PP; Huang RL; Lai HC; Cheung ANY; Tse KY; Ngan HYS; Wong AST
Nat Commun; 2018 Jun; 9(1):2270. PubMed ID: 29891938
[TBL] [Abstract][Full Text] [Related]
3. Engagement of collagen-binding integrins promotes matrix metalloproteinase-9-dependent E-cadherin ectodomain shedding in ovarian carcinoma cells.
Symowicz J; Adley BP; Gleason KJ; Johnson JJ; Ghosh S; Fishman DA; Hudson LG; Stack MS
Cancer Res; 2007 Mar; 67(5):2030-9. PubMed ID: 17332331
[TBL] [Abstract][Full Text] [Related]
4. Beyond a tumor suppressor: Soluble E-cadherin promotes the progression of cancer.
Hu QP; Kuang JY; Yang QK; Bian XW; Yu SC
Int J Cancer; 2016 Jun; 138(12):2804-12. PubMed ID: 26704932
[TBL] [Abstract][Full Text] [Related]
5. Cadherin and catenin expression in normal human bronchial epithelium and non-small cell lung cancer.
Smythe WR; Williams JP; Wheelock MJ; Johnson KR; Kaiser LR; Albelda SM
Lung Cancer; 1999 Jun; 24(3):157-68. PubMed ID: 10460003
[TBL] [Abstract][Full Text] [Related]
6. Soluble adhesion molecules E-cadherin, intercellular adhesion molecule-1, and E-selectin as lung cancer biomarkers.
Gogali A; Charalabopoulos K; Zampira I; Konstantinidis AK; Tachmazoglou F; Daskalopoulos G; Constantopoulos SH; Dalavanga Y
Chest; 2010 Nov; 138(5):1173-9. PubMed ID: 20495107
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of MMPs by soluble E-cadherin in human lung tumor cells.
Nawrocki-Raby B; Gilles C; Polette M; Bruyneel E; Laronze JY; Bonnet N; Foidart JM; Mareel M; Birembaut P
Int J Cancer; 2003 Jul; 105(6):790-5. PubMed ID: 12767064
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
De Leeuw WJ; Berx G; Vos CB; Peterse JL; Van de Vijver MJ; Litvinov S; Van Roy F; Cornelisse CJ; Cleton-Jansen AM
J Pathol; 1997 Dec; 183(4):404-11. PubMed ID: 9496256
[TBL] [Abstract][Full Text] [Related]
9. High Concentrations of Serum Soluble E-Cadherin in Patients With Q Fever.
Mezouar S; Omar Osman I; Melenotte C; Slimani C; Chartier C; Raoult D; Mege JL; Devaux CA
Front Cell Infect Microbiol; 2019; 9():219. PubMed ID: 31293984
[TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of hypoxia-inducible factor 1α, TWIST and E-cadherin is associated with aggressive tumor phenotypes in endometrioid endometrial carcinoma.
Feng Z; Gan H; Cai Z; Li N; Yang Z; Lu G; Chen J
Jpn J Clin Oncol; 2013 Apr; 43(4):396-403. PubMed ID: 23372184
[TBL] [Abstract][Full Text] [Related]
11. The predictive value of serum soluble E-cadherin levels in breast cancer patients undergoing preoperative systemic chemotherapy.
Hofmann G; Balic M; Dandachi N; Resel M; Schippinger W; Regitnig P; Samonigg H; Bauernhofer T
Clin Biochem; 2013 Oct; 46(15):1585-9. PubMed ID: 23792261
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium.
Shaco-Levy R; Sharabi S; Benharroch D; Piura B; Sion-Vardy N
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):226-32. PubMed ID: 18295959
[TBL] [Abstract][Full Text] [Related]
13. Beta-catenin and E-cadherin expression patterns in high-grade endometrial carcinoma are associated with histological subtype.
Schlosshauer PW; Ellenson LH; Soslow RA
Mod Pathol; 2002 Oct; 15(10):1032-7. PubMed ID: 12379748
[TBL] [Abstract][Full Text] [Related]
14. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
[TBL] [Abstract][Full Text] [Related]
15. The invasive phenotype of placenta accreta extravillous trophoblasts associates with loss of E-cadherin.
Duzyj CM; Buhimschi IA; Motawea H; Laky CA; Cozzini G; Zhao G; Funai EF; Buhimschi CS
Placenta; 2015 Jun; 36(6):645-51. PubMed ID: 25904157
[TBL] [Abstract][Full Text] [Related]
16. E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma.
Bukholm IK; Nesland JM; Kåresen R; Jacobsen U; Børresen-Dale AL
J Pathol; 1998 Jul; 185(3):262-6. PubMed ID: 9771479
[TBL] [Abstract][Full Text] [Related]
17. [Cadherins in malignancies of the female genital tract].
Piura B; Rabinovich A; Aizenberg N; Wolfson M
Harefuah; 2005 Apr; 144(4):261-5, 303, 302. PubMed ID: 15889610
[TBL] [Abstract][Full Text] [Related]
18. The clinical significance of soluble E-cadherin in nonsmall cell lung cancer.
Charalabopoulos K; Gogali A; Dalavaga Y; Daskalopoulos G; Vassiliou M; Bablekos G; Karakosta A; Constantopoulos S
Exp Oncol; 2006 Mar; 28(1):83-5. PubMed ID: 16614715
[TBL] [Abstract][Full Text] [Related]
19. Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin.
Zuo JH; Zhu W; Li MY; Li XH; Yi H; Zeng GQ; Wan XX; He QY; Li JH; Qu JQ; Chen Y; Xiao ZQ
J Cell Biochem; 2011 Sep; 112(9):2508-17. PubMed ID: 21557297
[TBL] [Abstract][Full Text] [Related]
20. Sequential changes in cadherin-catenin expression associated with the progression and heterogeneity of primary oesophageal squamous carcinoma.
Sanders DS; Bruton R; Darnton SJ; Casson AG; Hanson I; Williams HK; Jankowski J
Int J Cancer; 1998 Dec; 79(6):573-9. PubMed ID: 9842964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
